Skip to content
Home/Companies/Healthcare/Uroviva
Uroviva

Uroviva

Healthcare·Switzerland·Exited 2025·Held 8yr
Entry
2017
Hold
8yr
Exit
2025

Who owns Uroviva?

Uroviva was owned by ECM Equity Capital Management through German Equity Partners IV (2013 vintage) from 2017 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

ECM Equity Capital Management
Investor
ECM Equity Capital Management
German Equity Partners IV · 2013 · Buyout

Key facts

HQSwitzerland
SectorHealthcare
StatusAcquired
Websitewww.uroviva.ch
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from German Equity Partners IV

Other portfolio companies in the same fund.

Apostroph Group
Apostroph Group
Exited 2025
Business ServicesSwitzerland· 2017
to
Dermatologikum
Exited 2023
HealthcareGermany· 2016
to
Leitner
Leitner
Active
ConsumerGermany· 2014
Bergmann
Bergmann
Active
IndustrialsGermany· 2013
MediFox
Exited 2018
HealthTechGermany· 2013
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Uroviva

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Uroviva.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue